TECH Bio-Techne
- 82.840
- -0.660-0.79%
- 83.890
- +1.050+1.27%
Bio-Techne News
Bio-Techne(TECH.US) Director Sells US$335.38K in Common Stock
$Bio-Techne(TECH.US)$ Director HIGGINS JOHN L sold 4,000 shares of common stock on May 14, 2024 at an average price of $83.8443 for a total value of $335.38K.Source: Announcement What is statement of
Bio-techne Insider Sold Shares Worth $335,377, According to a Recent SEC Filing
John L Higgins, Director, on May 14, 2024, sold 4,000 shares in Bio-techne (TECH) for $335,377. Following the Form 4 filing with the SEC, Higgins has control over a total of 36,608 shares of the compa
Form 144 | Bio-Techne(TECH.US) Director Proposes to Sell 335.38K in Common Stocks
SEC FILLINGS DISCLOSED/ May 14, $Bio-Techne(TECH.US)$ Director JOHN L HIGGINS intends to sell 4,000 shares of its common stock on May 14, with a total market value of approximately $335.38K. Source
Bio-Techne Corporation (TECH) Declined on Weak Q4 Results
5 Stocks at the Forefront of S&P 500 ETF's Latest Rally
BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024
BIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT)
Bio-Techne | 10-Q: Quarterly report
Argus Adjusts Price Target on Bio-Techne to $95 From $90, Keeps Buy Rating
Bio-Techne (TECH) has an average rating of buy and price targets ranging from $65 to $95, according to analysts polled by Capital IQ.
Which Large-Cap Stocks Are Winning This Earnings Season? 15 Stocks To Watch (April 28-May 4, 2024)
These large-cap stocks were the best performers in the last week amid earnings season. Are they in your portfolio?Carvana Co. (NYSE:CVNA) shares escalated 39.1% after it reported Q1 revenue of $3.061
Bio-Techne Corporation Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Bio-Techne Corporation (NASDAQ:TECH) defied analyst predictions to release its quarterly results, which were ahead of market expectations. Results were good overall, with revenues beating analyst
Bio-Techne To Go Ex-Dividend On May 10th, 2024 With 0.08 USD Dividend Per Share
May 3rd - $Bio-Techne(TECH.US)$ is trading ex-dividend on May 10th, 2024. Shareholders of record on May 13th, 2024 will receive 0.08 USD dividend per share on May 24th, 2024. The ex-dividend date
Benchmark Reiterates Buy on Bio-Techne, Maintains $95 Price Target
Benchmark analyst Robert Wasserman reiterates Bio-Techne with a Buy and maintains $95 price target.
Analysts' Top Healthcare Picks: Bio-Techne (TECH), Gilead Sciences (GILD)
RBC Capital Adjusts Price Target on Bio-Techne to $72 From $71, Sector Perform Rating Kept
Bio-Techne (TECH) has an average rating of Buy and price targets ranging from $65 to $95, according to analysts polled by Capital IQ. Price: 69.79, Change: -3.67, Percent Change: -5.00
Bio-Techne Is Maintained at Outperform by Baird
Bio-Techne Is Maintained at Outperform by Baird
Baird Maintains Outperform on Bio-Techne, Raises Price Target to $81
Baird analyst Catherine Schulte maintains Bio-Techne (NASDAQ:TECH) with a Outperform and raises the price target from $73 to $81.
Bio-Techne Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/02/2024 10.26% Baird $73 → $81 Maintains Outperform 04/18/2024 11.63% Deutsche Bank $85 → $82 Maintains
KeyBanc Remains a Buy on Bio-Techne (TECH)
Analysts Offer Insights on Healthcare Companies: Bio-Techne (TECH) and Amneal Pharmaceuticals (AMRX)
Analysis
Price Target
No Data
